🔎 Trials Near Me

Home › Cutaneous Lupus Erythematosus › Texas

Pag-aaral pangklinika para sa Cutaneous Lupus Erythematosus sa Texas

5 pag-aaral para sa Cutaneous Lupus Erythematosus ang naghahanap ng mga kalahok sa mga site sa Texas.

Opisyal na teksto ng pag-aaral (English)

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  • North Texas Center for Clinical Research, Frisco
  • Accurate Clinical Research, Humble
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07355218

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

  • Allen Arthritis, Allen
  • Arthritis and Rheumatology Research Institute PLLC, Allen
  • Arthritis Care of Texas, Corpus Christi
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07332481

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

  • Investigative Site, Allen
  • Investigative Site, Arlington
  • Investigative Site, Colleyville
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07260877

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

  • US04-0, Irving
  • US02-0, San Antonio
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT06625671

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

  • University of Texas Southwestern, Dallas
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT01510067

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.